INVESTOR ALERT: Investigation of uniQure N.V. (QURE) Announced by Holzer & Holzer, LLC ATLANTA, Nov. 03, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether uniQure N.V. (“uniQure” or “the Company”) (NASDAQ: QURE) complied with federal securities laws. On November 3, 2025, uniQure disclosed it had a pre-Biologics License Application (“BLA”) meeting with the U.S. Food and Drug Administration (“FDA”) and that based on the meeting, “uniQure believes that the FDA currently no longer agrees th ...